TCL Archive IOM Panel: NCI Clinical Trials Groups At “Breaking Point,” More Funds Needed. April 16, 2010
TCL Archive In Brief: NCI May Lose Some Hard-Won New Positions For Ford’s Federal Job Cuts; Ask $9898.5 Million For Fiscal 1976 October 25, 1974
TCL Archive Lilly drug Alimta misses the target, but wins ODAC endorsement for lung cancer. FDA’s Pazdur tells ODAC that decision on Alimta requires clinical judgment. July 30, 2004
